News + Insights

21 July 2022

What is the UKCA mark, and how does it differ to CE marking?

As with many things post-Brexit, conformity marking of medical devices and IVDs has become much more complex for...

08 July 2022

What is regulatory affairs in the healthcare sector, and what does it consist of?

Given the rapidly changing environments, roles and responsibilities recently, we take a minute to just remind ourselves and...

23 June 2022

Biosimilars development: Successful scientific advice to accelerate development and registration

Woodley BioReg delivered successful scientific advice to accelerate biosimilars development and the registration of a biological product. Our...

13 May 2022

UK routes to registration for medicinal cannabis

This is the fourth and final blog in our series on medicinal cannabis. To view the others, click here....

13 May 2022

The medical applications of cannabis

This is the third blog in our medicinal cannabis series. You can view the first and second article here to...

13 May 2022

The regulatory background of medicinal cannabis in the EU and the UK

Second in our medicinal cannabis blog series, this article explores the regulatory background of medicinal cannabis in the...

13 May 2022

An introduction to medicinal cannabis

One of the most commonly proscribed drugs used throughout the world is cannabis. The drug has provoked both...

12 May 2022

Meet Alison Moore, Finance Assistant at Woodley BioReg

Can you summarise your role in one paragraph? I’m responsible for anything to do with finance and payroll...

09 May 2022

Healthcare regulatory affairs agency appoints senior consultant to expand reach into medical devices market

Regulatory affairs consultancy Woodley BioReg has appointed Bryan Lister as senior regulatory affairs consultant, specialising in medical devices...